Relationships between serum and meconium biomarkers of prenatal tobacco smoke exposure and their association with infant and early childhood growth Public Deposited
Downloadable ContentDownload PDF
- Last Modified
- March 22, 2019
Braun, Joe Mathias
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
- Prenatal active and secondhand tobacco smoke exposures remain a prevalent and preventable risk factor for adverse infant and childhood health outcomes. I used a prospective birth cohort of 389 mothers and their infants who were followed from early pregnancy to three years of age to address two specific aims. First, I validated the utility of meconium as a biological matrix to quantify prenatal tobacco smoke exposure. Second, I examined the association between prenatal tobacco smoke exposure and early childhood body mass index (BMI). I validated the utility of meconium tobacco smoke metabolites as biomarkers of prenatal tobacco smoke exposure against self-report and serum cotinine biomarkers of tobacco smoke exposure. I also estimated and compared associations between meconium and serum metabolite concentrations and infant birth weight. Nicotine, cotinine, and trans-3'-hydroxycotinine were detected in the majority of meconium samples (57-80%). Meconium tobacco smoke metabolite concentrations were positively associated with self-report and serum cotinine biomarkers of tobacco smoke exposure. The association between meconium metabolite concentrations and infant birth weight was similar to serum cotinine associations. Meconium is a promising biological matrix to quantify prenatal environmental toxicant exposure; however, meconium tobacco smoke metabolite concentrations did not provide additional information that could be obtained from a single serum cotinine measurement. In the second aim, prenatal tobacco smoke exposures were quantified using maternal self-report and serum cotinine biomarkers. BMI was calculated from weight and height measurements taken at birth, 4 weeks, and 1, 2, and 3 years of age. During pregnancy, 51% of women had cotinine levels consistent with SHS exposure and 10% had cotinine concentrations indicative of active smoking. After adjustment for confounders, both self-report and serum biomarkers of active tobacco smoke exposures were associated with elevated BMI at 2 and 3 years of age. Estimates of association between self-reported SHS exposures and BMI were attenuated towards the null relative to serum cotinine concentration associations. These results suggest that prenatal tobacco smoke exposures may play a role in the development of overweight in early childhood and that self-reported prenatal SHS exposures are non-differentially misclassified, resulting in biased estimates of association with childhood BMI.
- Date of publication
- May 2010
- Resource type
- Rights statement
- In Copyright
- "... in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Epidemiology."
- Daniels, Julie
- Degree granting institution
- University of North Carolina at Chapel Hill
- Place of publication
- Chapel Hill, NC
- Open access
This work has no parents.
|Relationships between serum and meconium biomarkers of prenatal tobacco smoke exposure and their association with infant and early childhood growth||2019-04-10||Public||